| scholarly article | Q13442814 |
| P2093 | author name string | Go Wakabayashi | |
| Minoru Tanabe | |||
| Masaki Kitajima | |||
| Motohide Shimazu | |||
| Shigeyuki Kawachi | |||
| Ken Hoshino | |||
| Yasuhide Morikawa | |||
| Tomohisa Kadomura | |||
| Hiroaki Seki | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver transplantation | Q1368191 |
| P304 | page(s) | 1959-1961 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation | |
| P478 | volume | 73 |
| Q41960411 | A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure |
| Q47752841 | A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation |
| Q43241149 | A survival case of ABO-incompatible liver transplantation complicated with severe preoperative infection and subsequent overwhelming postsplenectomy infection |
| Q37367628 | ABO incompatible liver transplantation as a bridge to treat HELLP syndrome |
| Q42204862 | ABO-Incompatible Living Donor Liver Transplantation from Hepatitis B Core Antibody Positive Donor to Hepatitis C Liver Cirrhosis Recipient: A Case Report. |
| Q41516975 | ABO-incompatible liver transplantation for severe hepatitis B patients |
| Q93140245 | ABO-incompatible liver transplantation: Is it a viable option with modern innovation? |
| Q46468627 | ABO-incompatible liver transplantation: a new therapeutic option for patients with acute liver failure in Chile |
| Q34156791 | ABO-incompatible living donor liver transplantation without graft local infusion and splenectomy. |
| Q37984656 | ABO-incompatible organ transplantation. |
| Q35524699 | ABO-incompatible renal transplantation: From saline flushes to antigen-specific immunoadsorption-Tools to overcome the barrier |
| Q79635351 | Adult ABO-incompatible liver transplantation by intraportal transfusion of donor-specific antigen: a case report |
| Q50114384 | Biliary reconstruction in right lobe living-donor liver transplantation: Comparison of different techniques in 321 recipients |
| Q37310975 | Current concept of small-for-size grafts in living donor liver transplantation |
| Q28077320 | Current techniques for AB0-incompatible living donor liver transplantation |
| Q36746806 | Current trends in live liver donation |
| Q53546809 | Determination of specimen storage conditions for measuring isoagglutinin titers. |
| Q46594244 | Effect of intraportal infusion to improve small for size graft injury in living donor adult liver transplantation |
| Q53521067 | Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and resu |
| Q50531619 | End-stage liver cirrhosis with severe autoimmune hemolytic anemia, treated by blood type-incompatible living donor liver transplantation: a case report. |
| Q81886643 | Evolution of living donor liver transplantation over 10 years: experience of a single center |
| Q39965408 | Feasible usage of ABO incompatible grafts in living donor liver transplantation |
| Q37624525 | First successful perinatal management of pregnancy after ABO-incompatible liver transplantation |
| Q41111934 | Helicobacter cinaedi bacteremia with cellulitis after ABO-incompatible living-donor liver transplantation: Case report |
| Q92606381 | Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation |
| Q51794422 | Impact of intraportal donor-specific leukocyte transfusion for adult ABO-incompatible liver transplantation. |
| Q46198276 | Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT. |
| Q43660500 | Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study. |
| Q46106647 | Liver transplantation: Evading antigens-ABO-incompatible liver transplantation |
| Q88673219 | Liver transplantation: Japanese contributions |
| Q35068055 | Living donor liver transplantation |
| Q44669532 | Living donor liver transplantation with special reference to ABO-incompatible grafts and small-for-size grafts |
| Q36063337 | Living donor liver transplantation: Eastern experiences |
| Q53832478 | Long-term outcomes of ABO-incompatible pediatric living donor liver transplantation. |
| Q45359031 | Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report |
| Q60932740 | Low Titers of Antidonor ABO Antibodies After ABO-Incompatible Living Donor Liver Transplantation: A Long-Term Follow-Up Study |
| Q37848741 | Management of ABO-incompatible living-donor liver transplantation: past and present trends |
| Q46512704 | New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion, and preservation of spleen |
| Q46453010 | New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange |
| Q42695184 | Outcomes after liver transplantation in accordance with ABO compatibility: A systematic review and meta-analysis |
| Q79633266 | Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience with 335 consecutive cases |
| Q81422881 | Present status of ABO-incompatible living donor liver transplantation in Japan |
| Q35994608 | Progress in living donor liver transplantation |
| Q80335933 | Remaining caudate lobe in the right lobe graft in living donor liver transplantation: a blind spot? |
| Q41310008 | Results of ABO-incompatible liver transplantation using a simplified protocol at a single institution |
| Q39444886 | Risk factor for ischemic-type biliary lesion after ABO-incompatible living donor liver transplantation. |
| Q38870030 | Single-Center Experience of ABO-Incompatible Living-Donor Liver Transplantation With a New Simplified Intravenous Immunoglobulin Protocol: A Propensity Score-Matching Analysis. |
| Q41573767 | Steroid minimization immunosuppression protocol using basiliximab in adult living donor liver transplantation for hepatitis C virus-related cirrhosis |
| Q53868277 | Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases. |
| Q80223551 | Successful ABO incompatible living donor liver transplantation in a patient with high isoagglutinin titer using high-dose intravenous immunoglobulin |
| Q45160757 | Successful case of adult ABO-incompatible liver transplantation: beneficial effects of intrahepatic artery infusion therapy: a case report |
| Q38453652 | Successful experiences of ABO-incompatible adult living donor liver transplantation in a single institute: no immunological failure in 10 consecutive cases |
| Q40709704 | The optimal immunosuppressive protocol for the portal vein infusion of PGE1 and methylprednisolone in pediatric liver transplantation for fulminant hepatic failure of unknown etiology |
| Q48374184 | The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience |
| Q79439021 | The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation |
| Q56998322 | The use of prostaglandins in the immediate postsurgical liver transplant period |
| Q46631784 | Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation |
Search more.